Concepedia

Mingzhao Gao

MG

Statistics

Publications

5

Citations

226

H-Index

5

Active since

2018

Affiliations

Chinese Academy of Sciences(Current)

Shanghai Institute of Materia Medica

University of Chinese Academy of Sciences

Mingzhao Gao is an author at Chinese Academy of Sciences specializing in medicine, oncology, and pharmacology.

Publications per year

2018–2019

5

Publications

5

Pharmacologic characterization of fluzoparib, a novel poly(<scp>ADP</scp>‐ribose) polymerase inhibitor undergoing clinical trials

Lei Wang, Changyong Yang, Chengying Xie et al. · Cancer Science · 2019 · 93 citations · Full text

, , +16

<scp>STAT</scp>3 activation confers trastuzumab‐emtansine (T‐<scp>DM</scp>1) resistance in <scp>HER</scp>2‐positive breast cancer

Lei Wang, Quanren Wang, Mingzhao Gao et al. · Cancer Science · 2018 · 56 citations · Full text

, , +17

<scp>SHR</scp>‐A1403, a novel c‐mesenchymal‐epithelial transition factor (c‐Met) antibody‐drug conjugate, overcomes <scp>AZD</scp>9291 resistance in non‐small cell lung cancer cells overexpressing c‐Met

Mengya Tong, Mingzhao Gao, Yongping Xu et al. · Cancer Science · 2019 · 27 citations · Full text

, , +17

Pharmacological characterization of <scp>TQ</scp>05310, a potent inhibitor of isocitrate dehydrogenase 2 R140Q and R172K mutants

Mingzhao Gao, Hongmei Zhu, Fu Li et al. · Cancer Science · 2019 · 26 citations · Full text

, , +13

Aberrant modulation of ribosomal protein S6 phosphorylation confers acquired resistance to MAPK pathway inhibitors in BRAF-mutant melanoma

Mingzhao Gao, Hongbin Wang, Xiangling Chen et al. · Acta Pharmacologica Sinica · 2018 · 24 citations · Full text

, , +16

1–5 of 5